Delivery Order SPE2DB25D3306-SPE2DB25FUCEX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,698.07 to AmerisourceBergen Drug Corp for Trokendi XR 25 mg capsules (30-count units) on October 28, 2025, with completion scheduled for October 29, 2025. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999 and extends through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order valued at $6,505.17 to AmerisourceBergen Drug Corp for Trokendi XR 100 mg capsules (30-count packaging) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trokendi XR is a brand-name pharmaceutical product indicated for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,248.46 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 50 mg capsules (30-count units) under a firm fixed-price contract. The award was made on December 10, 2025, with an ultimate completion date of December 11, 2025. This is an unset-aside, competitively awarded delivery order with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trokendi XR is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,966.96 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility. Trokendi XR is a branded anticonvulsant medication commonly used for seizure management and migraine prevention...
- The Defense Logistics Agency awarded a delivery order valued at $6,417.22 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count) on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units) with a ceiling value of $12,939.63. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is set to be completed by April 30, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $25,401.53 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count units) under a firm fixed-price contract type. The award was made on November 6, 2025, with an ultimate completion date of November 7, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Trokendi XR 50 mg capsules (30-count) with a ceiling value of $10,882.14. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trokendi XR 200 mg capsules (30-count) with a ceiling value of $2,107.48. The contract utilizes firm fixed pricing and is classified as a non-set-aside award, indicating it was competitively awarded through open procurement processes. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 23, 2025. This...
- The Defense Logistics Agency awarded a $6,530.33 delivery order to AmerisourceBergen Drug Corp for Trokendi XR 200 mg capsules (30-count packaging) under a firm fixed price contract type. The award was made on October 30, 2025, with an ultimate completion date of October 31, 2025, and no set-aside designation was used. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCEXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Trokendi XR 50 mg capsules (30-count packages) with a ceiling value of $1,803.93. This is a firm fixed price delivery order with an award date of July 14, 2025, and an ultimate completion date of July 15, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trokendi XR is a brand-name pharmaceutical product used for seizure management and migraine prevention, reflecting the company's role as a critical pharmaceutical supplier to federal military and healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. AmerisourceBergen's federal procurement portfolio demonstrates extensive capabilities in delivering specialty medications, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a major vendor in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/14/25 |